Inflammatory response in gut mucosa

The "inflammatory response in gut mucosa" refers to a complex biological process involving multiple cell types and signaling pathways that mediate immune defense and tissue repair within the intestinal lining. This response is characterized by activation of innate and adaptive immune cells—including macrophages, T cells, mast cells—and release of pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-alpha), interleukin 1 beta (IL‑1β), interleukin 6 (IL‑6), interferon gamma (IFN‑γ), among others. These mediators contribute to increased epithelial permeability, recruitment of additional inflammatory cells, disruption or restoration of epithelial barrier function depending on context and chronicity. Dysregulation or chronic activation of these responses underlies diseases such as ulcerative colitis and Crohn’s disease. Therapeutic strategies often focus on inhibiting key cytokines or signaling pathways—such as TNF-alpha inhibitors—to reduce pathological inflammation while preserving essential host defense functions. The term does not refer to a single molecular entity but encompasses an array of interacting molecules and cellular processes. Note: "Inflammatory response in gut mucosa" is not itself a canonical therapeutic target but describes an entire physiological/pathological process involving many potential drug targets. For structured data purposes it should be flagged as incorrect/not specific enough for use as an individual drug target entry.

Other names

Gut mucosal inflammationIntestinal inflammatory responseMucosal immune activation in the gut